Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Blood

• Publication date

  2013-12-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/blood-2013-08-519959PMID 24174627PMCID PMC3868925
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.

  2012cited by this paper
• Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.

  2011cited by this paper
• High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

  2011cited by this paper
• How I treat HIV-associated multicentric Castleman disease.

  2010cited by this paper
• Pivotal Advance: Kaposi's sarcoma‐associated herpesvirus (KSHV)‐encoded microRNA specifically induce IL‐6 and IL‐10 secretion by macrophages and monocytes

  2010cited by this paper
• HEALTH and HUMAN SERVICES

  2010cited by this paper
• Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease.

  2010cited by this paper
• CD20 expression in the HHV‐8‐infected lymphoid cells in multicentric Castleman disease

  2009cited by this paper
• HIV-associated multicentric Castleman disease

  2009cited by this paper
• Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease.

  2009cited by this paper
• Castleman Disease: An Update on Classification and the Spectrum of Associated Lesions

  2009cited by this paper
• Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV‐8)‐infected B cells in HIV+ multicentric Castleman disease (MCD)

  2008cited by this paper
• Intracellular Signaling Mechanisms and Activities of Human Herpesvirus 8 Interleukin-6

  2008cited by this paper
• Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.

  2007cited by this paper
• Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease

  2007cited by this paper
• Signal Transduction by Human Herpesvirus 8 Viral Interleukin-6 (vIL-6) IsModulated by the Nonsignaling gp80 Subunit of the IL-6 Receptor Complex and Is Distinct from Signaling Induced by Human IL-6

  2006cited by this paper
• Humanized anti-interleukin-6 receptor antibody

  2005cited by this paper
• Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease.

  2005cited by this paper
• IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

  2004cited by this paper
• Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders.

  2001cited by this paper
• Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Gene Expression as Revealed by DNA Arrays

  2001cited by this paper
• Serum viral interleukin-6 in AIDS-related multicentric Castleman disease.

  2001cited by this paper
• Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.

  2001cited by this paper
• Transcription Program of Human Herpesvirus 8 (Kaposi's Sarcoma-Associated Herpesvirus)

  2001cited by this paper
• High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

  2000cited by this paper
• State-of-the-Art Review: Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6

  2000cited by this paper
• Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease

  1999cited by this paper
• Kinetics of Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression

  1999cited by this paper
• p53 inhibition by the LANA protein of KSHV protects against cell death

  1999cited by this paper
• Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells.

  1999cited by this paper
• IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.

  1999cited by this paper
• KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways.

  1999cited by this paper
• Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma.

  1998cited by this paper
• Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis.

  1998cited by this paper
• Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1)

  1998cited by this paper
• Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines.

  1997cited by this paper
• Human herpesvirus 8 encodes a homolog of interleukin-6

  1997cited by this paper
• Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.

  1997cited by this paper
• Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells.

  1997cited by this paper
• A Kaposi’s Sarcoma-associated Herpesvirus-encoded Cytokine Homolog (vIL-6) Activates Signaling through the Shared gp130 Receptor Subunit*

  1997cited by this paper
• Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae

  1996cited by this paper
• Molecular Mimicry of Human Cytokine and Cytokine Response Pathway Genes by KSHV

  1996cited by this paper
• Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma

  1996cited by this paper
• Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients

  1996cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

  1995cited by this paper
• Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

  1995cited by this paper
• Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

  1994cited by this paper
• Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

  1990cited by this paper
• Interleukin-6 and the acute phase response.

  1990cited by this paper
• Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

  1989cited by this paper
• A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

  1985cited by this paper
• Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of the mediastinum and other locations

  1972cited by this paper
• Localized Mediastinal Lymph‐Node Hyperplasia Resembling Thymoma

  1958cited by this paper
• Localized mediastinal lymph‐node hyperplasia resembling thymoma

  1956cited by this paper

• EBV+ and Kaposi’s Sarcoma Herpesvirus‐Associated Multicentric Castleman Disease in a Patient With HIV Infection: A Case Report

  2026cites this paper
• Snapshot Look at Castleman Disease

  2026cites this paper
• Virally encoded interleukin-6 (vIL-6) coordinates with human IL-6 to modulate cytokine expression during KSHV infection

  2025cites this paper
• Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseases

  2025cites this paper
• Editorial: Community series in the regulation of the host immune activation in respiratory virus infections, volume II

  2025cites this paper
• Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndrome

  2025cites this paper
• Kaposi sarcoma herpesvirus (KSHV) inflammatory cytokine syndrome (KICS): a case study

  2025cites this paper
• A rare case of Castleman disease presented with diffuse ground glass nodules in both lungs: Case report

  2025cites this paper
• Castleman disease of stomach treated by endoscopic submucosal dissection: a case report and literature review

  2025cites this paper
• Design, development, and evaluation of gene therapeutics specific to KSHV-associated diseases

  2025cites this paper
• Spatial and Bulk Transcriptomics Reveal Distinct Molecular Signatures in Kaposi Sarcoma with and Without other KSHV-Associated Diseases

  2025cites this paper
• The critical impacts of cytokine storms in respiratory disorders

  2024cites this paper
• Sporadic Kaposi Sarcoma Following a COVID-19 Vaccine: Mere Coincidence or Something More?

  2024cites this paper
• Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines

  2024cites this paper
• Mouse models of Kaposi sarcoma-associated herpesvirus (KSHV).

  2024cites this paper
• The ‘Oma’s of the Gammas—Cancerogenesis by γ-Herpesviruses

  2024cites this paper
• Kaposi’s sarcoma unmasked by corticosteroids in an advanced HIV patient with tuberculosis immune reconstitution inflammatory syndrome

  2024cites this paper
• The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis

  2024cites this paper
• A LANA peptide inhibits tumor growth by inducing CHD4 protein cleavage and triggers cell death.

  2024cites this paper
• Kaposi Sarcoma as a Possible Cutaneous Adverse Effect of ChAdOx1 nCov-19 Vaccine: A Case Report

  2024cites this paper
• The Cytokine Storm of Multicentric Castleman Disease.

  2024cites this paper
• Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases

  2024cites this paper
• HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus

  2024influential citation
• Overview of Research Status in Castleman Disease.

  2024cites this paper
• PROTAC targeting cyclophilin A controls virus-induced cytokine storm

  2023cites this paper
• Remission after rituximab for HHV8+ MCD: what next?

  2023cites this paper
• Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies

  2023cites this paper
• Lymphomas with plasmablastic features: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology

  2023cites this paper
• Assessing Biomarkers in Viral Infection.

  2023cites this paper
• Immunotherapy for KSHV-associated diseases.

  2022cites this paper
• Kaposi’s sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy

  2022cites this paper
• Castleman's Disease with a Rare Paraduodenal Localization Treated by Laparoscopy: Case Report and Literature Review

  2022cites this paper
• Herpesviruses and Inflammasomes: One Sensor Does Not Fit All

  2022cites this paper
• Evidence for Multiple Subpopulations of Herpesvirus-Latently Infected Cells

  2022cites this paper
• Deconstructing the liquid architecture of human herpesvirus 8 diseases

  2022cites this paper
• Human herpes virus 8-related illness: still with us.

  2022cites this paper
• La maladie de Castleman

  2022cites this paper
• La maladie de Castleman : aspects anatomopathologiques

  2022cites this paper
• Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma

  2022cites this paper
• Characteristics of patients admitted to the ICU with Kaposi sarcoma herpesvirus-associated diseases

  2022cites this paper
• Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms

  2021cites this paper
• The Importance of Early Recognition of KSHV-mediated Syndromes: A Case Report.

  2021cites this paper
• Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018

  2021cites this paper
• Monocyte chemoattractant protein-induced protein 1 directly degrades viral miRNAs with a specific motif and inhibits KSHV infection.

  2021cites this paper
• An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease

  2021cites this paper
• Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases.

  2021cites this paper
• Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders

  2021cites this paper
• Emerging role of 18F-FDG PET/CT in Castleman disease: a review

  2021cites this paper
• Castleman disease

  2021cites this paper
• Primary Effusion Lymphoma: A Clinicopathological Study of 70 Cases

  2021cites this paper
• Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection

  2021cites this paper
• Kaposi's Sarcoma‐associated Herpesvirus—Antiviral Treatment

  2021cites this paper
• KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth

  2021cites this paper
• Multicentric Castleman disease and the evolution of the concept

  2021cites this paper
• AIDS Related Kaposi’s Sarcoma: A 20-Year Experience in a Clinic from the South-East of Romania

  2021cites this paper
• KSHV transactivator-derived small peptide traps coactivators to attenuate MYC function and kills leukemia and lymphoma

  2021cites this paper
• Hematological cancers in individuals infected by HIV.

  2021cites this paper
• Prevalence and Influence of the −174 G/C Polymorphism in the Interleukin-6 Gene in Arboviruses Infections

  2021cites this paper
• Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes

  2020cites this paper
• Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma

  2020cites this paper
• Mesenteric Castleman’s Disease: A Rare Cause of Mesenteric Masses: A Case Report and Literature Review

  2020cites this paper
• Unicentric Castleman disease and lymphoepithelial cyst of the parotid: A case report and review of the literature

  2020cites this paper
• Tocilizumab in Patients with Symptomatic Kaposi sarcoma Herpesvirus (KSHV)- associated Multicentric Castleman disease.

  2020cites this paper
• Ultrasound and radiological features of abdominal unicentric castleman's disease

  2020cites this paper
• KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression

  2020cites this paper
• A rare case: castleman’s disease

  2020cites this paper
• A Rare Case of the Newly Recognized Kaposi Sarcoma Herpesvirus-Associated Disease

  2020cites this paper
• A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.

  2020cites this paper
• Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome

  2020cites this paper
• Clinical and pathological features of kaposi sarcoma herpesvirus inflammatory cytokine syndrome: case report and review of the literature.

  2020cites this paper
• Multicentric Castleman's Disease with Disseminated Kaposi's Sarcoma: A Report of Prolonged Misdiagnosis

  2020cites this paper
• Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis

  2020cites this paper
• Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome

  2020cites this paper
• Rare retroperitoneal conditions that mimic uterine myoma

  2020cites this paper
• FDG PET/CT Findings of Castleman Disease Assessed by Histologic Subtypes and Compared with Laboratory Findings

  2020cites this paper
• Cytokine Storm

  2020cites this paper
• Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other KSHV-associated disorders.

  2020cites this paper
• Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.

  2019cites this paper
• Navigating the heterogeneous landscape of pediatric Kaposi sarcoma

  2019cites this paper
• Induction of Kaposi’s Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1

  2019cites this paper
• Evaluation of the therapeutic potential of several compounds in human herpesvirus 8 using a chimera virus mouse infection model

  2019cites this paper
• KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication

  2019cites this paper
• Kaposi sarcoma

  2019cites this paper
• Mesenteric Castleman’s disease mimicking neuroendocrine tumour

  2019cites this paper
• Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids

  2019cites this paper
• Castleman Disease

  2019cites this paper
• Kaposi Sarcoma-Associated Herpesvirus (KSHV).

  2019cites this paper
• Diagnosis and Management of Castleman Disease.

  2019cites this paper
• Viral, immunologic, and clinical features of primary effusion lymphoma.

  2019cites this paper
• Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.

  2018cites this paper
• KSHV activates unfolded protein response sensors but suppresses downstream transcriptional responses to support lytic replication

  2018cites this paper
• Interaction between DC-SIGN and DC-SIGNR with HHV-8 (LANA-1) and HIV-p24 in Castleman disease

  2018cites this paper
• Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives

  2018cites this paper
• KSHV induces immunoglobulin rearrangements in mature B lymphocytes

  2018cites this paper
• Emergence of Kaposi’s Sarcoma Herpesvirus-Associated Complications Following Corticosteroid Use in TB-IRIS

  2018cites this paper
• Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update.

  2018cites this paper
• AIDS-Associated Malignancies.

  2018cites this paper
• Biologic Agents in the Treatment of Multicentric Castleman Disease.

  2018cites this paper
• ADA2 Deficiency Mimicking Idiopathic Multicentric Castleman Disease

  2018cites this paper
• HIV‐Associated Cancers and Related Diseases

  2018cites this paper